CleanNA
Pre-clinicalCleanNA, founded in 2010 and spun off as a separate entity within the Double Helix Group in 2019, develops and manufactures proprietary magnetic bead-based reagents for automated DNA and RNA extraction. The company serves both research and diagnostic markets with products certified under an EN-ISO 13485 Quality Management System. Its mission is to support laboratories by reducing hands-on time and improving yield and quality for demanding downstream applications like NGS, CRISPR, and qPCR.
AI Company Overview
CleanNA, founded in 2010 and spun off as a separate entity within the Double Helix Group in 2019, develops and manufactures proprietary magnetic bead-based reagents for automated DNA and RNA extraction. The company serves both research and diagnostic markets with products certified under an EN-ISO 13485 Quality Management System. Its mission is to support laboratories by reducing hands-on time and improving yield and quality for demanding downstream applications like NGS, CRISPR, and qPCR.
Technology Platform
Proprietary magnetic bead-based chemistry for the automated isolation and purification of DNA and RNA from diverse sample types, optimized for integration with laboratory automation systems.
Opportunities
Risk Factors
Competitive Landscape
Competes against giants like Qiagen, Thermo Fisher, and Promega by specializing in automation-friendly, magnetic bead-based reagents and targeting niche applications with challenging samples. Differentiates on value-for-money and direct replacement of established products like AMPureXP beads.
Company Info
Contact
Therapeutic Areas
Partners
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile